Tranexamic Acid 100 mg/ml Solution for Injection, 5 x 5 ml
Tranexamic Acid 100 mg/ml Solution for Injection, 5 x 5 ml — Anticoagulants, Antiplatelets & Antihaemorrhagics, as a solution for injection, available for private-label manufacture from 10,000 units, produced in India. Below, the active substance of this Anticoagulants, Antiplatelets & Antihaemorrhagics product appears under its International Nonproprietary Name, with the strength per unit that the specification gives.
| Dosage form | Solution for injection |
|---|---|
| Pack | 5 x 5 ml clear glass ampoules |
| Minimum order | 10,000 units |
| Manufactured in | India |
| Registration | Not yet registered in Iraq — product open for exclusive registration in your name |
| Market status | Choose your market: Iraq · Gulf · EuropeIraq: the registration status is in the row above.Gulf: on offer for the Gulf states. The Gulf pageEurope: on offer for European buyers. Details |
| Documents | Certificate of Analysis, Certificate of Origin, Certificate of Conformity, Free Sale Certificate and MSDS — available on request. |
| Products Library | Open this formulation's card (F1988) |
About this formulation
This formulation, “Tranexamic Acid 100 mg/ml Solution for Injection, 5 x 5 ml”, belongs to the “Anticoagulants, Antiplatelets & Antihaemorrhagics” range; it is made in India for private-label brands from 10,000 units per SKU. Our production site is not yet registered in Iraq, so the product is open for registration in your name. The production time is set in our offer for this product. The declared active is Tranexamic acid 100 mg.
The “Anticoagulants, Antiplatelets & Antihaemorrhagics” range: Rivaroxaban in four strengths, 2.5, 10, 15 and 20 mg, and apixaban at 2.5 and 5 mg hold the factor Xa end of this cardiology shelf.
Related formulations
Active ingredients
- Tranexamic acid 100 mg per ml
Solution for injection with 100 mg tranexamic acid per ml (500 mg per 5 ml ampoule), an antifibrinolytic given by a healthcare professional, 5 clear glass ampoules of 5 ml per box.
Market status in detail
Iraq. Our production site for this line has no Iraqi file yet. The site registration comes first; the product is then filed in your name; for a medicine, with a new CPP. How filing works in Iraq
Gulf. This product is on offer for the Gulf states. Tell us the country and the quantity, and we answer with the offer and the documents we supply.
Country pages: Saudi Arabia · UAE · Kuwait · Qatar · Oman · Bahrain
Europe. This product is on offer for European buyers. Tell us the country and the quantity, and we answer with the offer and the documents we supply.
Change market: Iraq · Gulf · Europe · All markets
Shipping and document legalisation for your country are calculated separately and stated in the offer.